Welcome to the International PhD Program in Biomedical Engineering (IPBME) at Taipei Medical University, Taiwan.
IPBME offers a PhD program at Taipei Medical University (TMU) College of Biomedical Engineering (CBME), open exclusively to non-Taiwanese students
All lectures, seminars and research are carried out in English
IPBME aims for students to obtain a PhD in four years or less
Scholarships and tuition waivers are available for up to three years of study
Dual-diploma PhD studies are available, in partnership with Japanese, American and French institutions.
Students have the opportunity for international research projects and travel.
The goals of IPBME are:
To integrate the research and teaching resources of the whole College of Biomedical Engineering
To involve students in international research projects, and provide them with knowledge, tools, and expertise in biomedical engineering that can serve their future developments and career and the needs of their home country
To enhance students’ ability to communicate scientific information in English
To foster students’ talents to address scientific and social trends at national and global levels
STUDYING BIOMEDICAL ENGINEERING
Biomedical Engineering is an essential part of the economy for both developed and developing countries. As lifespan and average age of citizens continue to rise, the demand for biomedical devices will continue to expand. As countries become wealthier and more patients can afford treatment, prosthetics, implants and novel therapeutics will also continue to expand. We envision the convergence of both trends will create urgent needs for engineers with solid medical exposure experiences.
As such, a PhD in Biomedical Engineering is an excellent investment for your future career potential
BIOMATERIALS, TISSUE ENGINEERING & REGENERATIVE MEDICINE
artificial heart valves
MEDICAL DEVICES & INSTRUMENTATION
continuous glucose monitors
MRI, CT and live imaging
wearable device sensors
NANOMEDICINE & DRUG DELIVERY
new forms of drug to improve cancer treatment
targeted medicines for heart disease, cancer and brain disorders